Delivery Order SPE2DB20D1100-SPE2DB25FD1P6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 mg/2 ml pen injectors, valued at $6,777.99, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of the company's ongoing pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,625.24 by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of DUPIXENT 300 mg/2 ml pen injectors (2 ml). The contract is a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $29,756.49 to AmerisourceBergen Drug Corp for the supply of DUPIXENT 300 mg/2 ml pen injectors. This firm fixed-price, competitively awarded delivery order was issued on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order...
- The Defense Logistics Agency awarded a $4,810.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 MG/2 ML pen injectors (2 ML) on October 16, 2025, with an ultimate completion date of October 17, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement fulfilling immediate medical supply needs within the federal healthcare system. The award was placed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 MG/2 ML pen injections with a ceiling value of $4,147.68 under a firm fixed price contract type. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 MG/2 ML pen injectors valued at $7,550.30 under a firm fixed price contract. The award was made on July 21, 2025, with an ultimate completion date of July 22, 2025, and represents a non-set-aside competitive award. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $8,632.83 to AmerisourceBergen Drug Corp for DUPIXENT 300 MG/2 ML pen injectors (2ML). The contract, executed on August 28, 2025, with completion targeted for August 29, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through competitive procurement processes. This...
- The Defense Logistics Agency awarded a $26,840.77 delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 MG/2 ML pen injectors on September 24, 2025, with completion scheduled for September 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical products will be performed at the company's corporate...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 3, 2025, by the Defense Logistics Agency (DLA) for DUPIXENT 300 mg/2 ml pen injectors valued at $10,570.09 under a firm fixed-price contract. The order is set to be completed by September 4, 2025, with performance conducted at the company's corporate office location in Conshohocken, Pennsylvania. This competitively awarded delivery order represents a single pharmaceutical supply transaction within DLA's medical procurement...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 4, 2025, by the Defense Logistics Agency (DLA) for Dupixent 200 mg/1.14 ml pen auto-injectors. The contract is valued at $1,935.84 with a firm fixed price structure and an ultimate completion date of August 5, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD1P6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 MG/2 ML pen injectors valued at $35,018.51 under a firm fixed price contract type. The delivery order, issued on June 30, 2025, with an ultimate completion date of July 1, 2025, represents a non-competitive award to the prime contractor. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026 that enables the contractor to supply a broad range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The company's federal contract portfolio demonstrates extensive experience delivering specialty medications, vaccines, and medical devices across multiple therapeutic domains. As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen has demonstrated capability to meet federal procurement requirements and is positioned as one of multiple anticipated contractors for the DLA Troop Support's Pharmaceutical Prime Vendor Global Program Generation V contracts, which will establish regional supply relationships across the globe.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.0k | 6/30/25 |